News
It's the second consecutive month in which operating margins tightened, Strata's data shows.
The report compares cost, care, patient experience and more to brick-and-mortar care, ahead of the expiration of the waiver.
The potential return on investment from reducing these inequities could be enormous, a Deloitte analysis finds.
Various forms of a potential separation are reportedly under consideration, though specifics remain unclear.
The drugmaker says it believes the rebate model is legally permissible and needed to improve the integrity of the 340B program.
The HELP Committee wanted to punish de la Torre for invoking his Fifth Amendment right, the lawsuit says.
UMC has been able to keep its ER open, but other services have been disrupted.
An audit finds $7.8M in federal funds were claimed for enrollees who were incorrectly assigned to eligibility groups.
The rebates paid by drug companies will be deposited into the Medicare Trust Fund.
Denial rates have steadily increased, with providers seeing rejection rates as high as 10% to 15%.